Pharma and Biotech
| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1027.9% | n/a |
| ROCE | 4172.7% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 13.3 | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | -84.0% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-21 | 0.32 | (5.90) | (3.05)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-22 | 0.62 | (5.57) | (2.65)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-23 | 0.08 | (4.26) | (1.75)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-24 | 1.91 | (3.01) | (0.87)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Mar-25 | 0.31 | (3.29) | (0.65)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Change of Auditor | 25-Nov-2025 | 07:00 | RNS |
| Total Voting Rights | 31-Oct-2025 | 17:00 | RNS |
| Chill Agrees Settlement with Former Advisers | 23-Oct-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 0.77p |
| Change Today | 0.008p |
| % Change | -1.08 % |
| 52 Week High | 2.15 |
| 52 Week Low | 0.75 |
| Volume | 56,370 |
| Shares Issued | 522.93m |
| Market Cap | £4.01m |
| Beta | 0.16 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 10:01 | 52,500 @ 0.77p |
| 09:43 | 16 @ 0.80p |
| 09:43 | 124 @ 0.80p |
| 09:43 | 140 @ 0.75p |
| 09:43 | 66 @ 0.75p |
You are here: research